Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,913 | 102 | 56.3% |
| Travel and Lodging | $1,427 | 6 | 42.0% |
| Education | $56.06 | 3 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $1,427 | 6 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $412.19 | 23 | $0 (2023) |
| Amgen Inc. | $390.37 | 14 | $0 (2020) |
| ABBVIE INC. | $187.72 | 9 | $0 (2023) |
| Novo Nordisk Inc | $142.06 | 8 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $137.67 | 10 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $123.58 | 3 | $0 (2019) |
| Allergan, Inc. | $88.59 | 6 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $67.79 | 5 | $0 (2020) |
| Lilly USA, LLC | $65.69 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $86.78 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($38.18) |
| 2022 | $115.56 | 6 | ABBVIE INC. ($65.59) |
| 2021 | $174.66 | 9 | Boehringer Ingelheim Pharmaceuticals, Inc. ($91.51) |
| 2020 | $208.36 | 13 | Amgen Inc. ($85.19) |
| 2019 | $639.80 | 37 | Amgen Inc. ($125.13) |
| 2018 | $342.32 | 18 | Amgen Inc. ($95.51) |
| 2017 | $1,828 | 24 | Intuitive Surgical, Inc. ($1,427) |
All Payment Transactions
111 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/28/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug), LIVALO | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/06/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: DIABETES | ||||||
| 02/08/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: DIABETES | ||||||
| 01/12/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $34.74 | General |
| Category: NEUROSCIENCE | ||||||
| 09/07/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: NEUROSCIENCE | ||||||
| 06/30/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Diabetes | ||||||
| 05/18/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $13.26 | General |
| Category: Cardiovascular | ||||||
| 02/16/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.84 | General |
| Category: NEUROSCIENCE | ||||||
| 01/27/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: NEUROSCIENCE | ||||||
| 01/13/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Diabetes | ||||||
| 12/15/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/27/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: NEUROSCIENCE | ||||||
| 09/07/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: NEUROSCIENCE | ||||||
| 07/08/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), TRIJARDY XR | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: DIABETES | ||||||
| 07/02/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/04/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $27.23 | General |
| Category: DIABETES | ||||||
| 02/08/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: DIABETES | ||||||
| 01/08/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: DIABETES | ||||||
| 09/16/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Bone Health | ||||||
| 08/03/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Bone Health | ||||||
| 07/30/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: DIABETES | ||||||
| 07/21/2020 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Neuroscience | ||||||
| 07/17/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: NEUROSCIENCE | ||||||
| 07/08/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 339 | 449 | $35,379 | $9,794 |
| 2022 | 27 | 5,871 | 9,536 | $303,897 | $172,943 |
| 2021 | 28 | 6,598 | 10,695 | $335,112 | $199,866 |
| 2020 | 31 | 4,764 | 7,281 | $235,607 | $133,171 |
All Medicare Procedures & Services
92 procedure records from CMS Medicare Utilization — Page 2 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 36 | 41 | $2,409 | $1,251 | 51.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 55 | 78 | $2,514 | $1,105 | 44.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 26 | 27 | $2,359 | $911.31 | 38.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 56 | 441 | $1,587 | $462.56 | 29.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 31 | 144 | $324.00 | $123.65 | 38.2% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 27 | 144 | $2,289 | $58.17 | 2.5% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 12 | 72 | $1,153 | $25.17 | 2.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 38 | 80 | $800.00 | $6.72 | 0.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 533 | 858 | $115,324 | $72,683 | 63.0% |
| 82306 | Vitamin d-3 level | Office | 2021 | 485 | 735 | $26,403 | $21,522 | 81.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 486 | 775 | $31,215 | $12,929 | 41.4% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2021 | 455 | 696 | $13,502 | $10,377 | 76.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 492 | 760 | $11,784 | $10,053 | 85.3% |
| 82746 | Folic acid level, serum | Office | 2021 | 444 | 655 | $11,257 | $9,512 | 84.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 526 | 855 | $19,550 | $9,012 | 46.1% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2021 | 485 | 771 | $10,877 | $6,890 | 63.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 517 | 829 | $17,577 | $6,435 | 36.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 40 | 40 | $5,443 | $5,114 | 94.0% |
| 90674 | Vaccine for influenza derived from cell cultures for administration into muscle, 0.5 ml dosage, quadrivalent, , preservative and antibiotic free | Office | 2021 | 163 | 163 | $8,299 | $4,731 | 57.0% |
| 83735 | Magnesium level | Office | 2021 | 465 | 713 | $7,702 | $4,725 | 61.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 114 | 481 | $11,880 | $4,422 | 37.2% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 294 | 448 | $5,601 | $4,316 | 77.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 42 | 48 | $4,489 | $2,951 | 65.7% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2021 | 444 | 710 | $3,430 | $2,826 | 82.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 92 | 92 | $11,423 | $2,686 | 23.5% |
About Dr. Christopher Parrish, D.O
Dr. Christopher Parrish, D.O is a Internal Medicine healthcare provider based in Princeton, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2008. The National Provider Identifier (NPI) number assigned to this provider is 1801042239.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Parrish, D.O has received a total of $3,396 in payments from pharmaceutical and medical device companies, with $86.78 received in 2023. These payments were reported across 111 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($1,913).
As a Medicare-enrolled provider, Parrish has provided services to 17,572 Medicare beneficiaries, totaling 27,961 services with total Medicare billing of $515,774. Data is available for 4 years (2020–2023), covering 92 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Princeton, WV
- Active Since 08/18/2008
- Last Updated 01/21/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1801042239
Products in Payments
- Da Vinci Surgical System (Device) $1,427
- Repatha (Biological) $222.74
- JARDIANCE (Drug) $207.75
- TRADJENTA (Drug) $185.43
- UBRELVY (Drug) $156.78
- FARXIGA (Drug) $137.67
- XARELTO (Drug) $64.97
- Prolia (Biological) $64.96
- VRAYLAR (Drug) $61.04
- EVENITY (Biological) $52.83
- Trulance (Drug) $52.03
- Aimovig (Biological) $49.84
- JANUVIA (Drug) $49.83
- INVOKANA (Drug) $47.43
- Ozempic (Drug) $45.93
- Tresiba (Drug) $41.40
- Vascepa (Drug) $40.52
- CHANTIX (Drug) $37.40
- Victoza (Drug) $32.00
- SPIRIVA RESPIMAT (Drug) $28.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Princeton
Dr. Ryan Lang, M.d, M.D
Internal Medicine — Payments: $443,150
Dr. Constance Winslow, M.d, M.D
Internal Medicine — Payments: $308,350
Dr. Kent Allenby, M.d, M.D
Internal Medicine — Payments: $209,745
Dr. Louis Baxter, Md, MD
Internal Medicine — Payments: $195,825
Mr. Ernest De La Cruz, Md, MD
Internal Medicine — Payments: $12,435
Srinivas Mendu, M.d, M.D
Internal Medicine — Payments: $10,996